Paris Boeckman, PharmD, BCEMP

756 posts

Paris Boeckman, PharmD, BCEMP

Paris Boeckman, PharmD, BCEMP

@EmergencyPharmD

Katılım Kasım 2016
172 Takip Edilen647 Takipçiler
Paris Boeckman, PharmD, BCEMP retweetledi
ACCP CRIT PRN
ACCP CRIT PRN@accpcritprn·
#JournalWatch @journal_CHEST More data for peripheral vasopressors! This study found that peripheral pressors offered a practical advantage and faster administration but wide practice pattern variation. #critPRN buff.ly/3MjWYo8
English
0
5
10
1.5K
Paris Boeckman, PharmD, BCEMP retweetledi
Eddy J. Gutierrez, MD
Eddy J. Gutierrez, MD@eddyjoemd·
How long is too long to be performing CPR in patients who suffer in-hospital cardiac arrest? Every patient and situation is obviously different but it shouldn’t come as a surprise that beyond 30 minutes, things don’t look too good. 🎩 tip to the authors. eddyjoemd.com/foamed/
Eddy J. Gutierrez, MD tweet media
English
5
112
305
54.5K
Paris Boeckman, PharmD, BCEMP retweetledi
Gary D Peksa 💊 🌱
Gary D Peksa 💊 🌱@garyDpeksa·
we have known the rate of thrombotic events with andexanet for a long time. 10% is not unexpected based on previous studies. ANNEXA-4 prelim analysis (2016) - 18% ANNEXA-4 full analysis (2019) - 10% ANNEXA-I (2024) - 10.3% #TwitteRx #FOAMed
English
1
3
12
3K
Paris Boeckman, PharmD, BCEMP retweetledi
Scott Dietrich
Scott Dietrich@PCC_PharmD·
New manuscript from EAST multicentered (10 site) AA vs 4PCC in trauma pt's showed no diff in transfusion requirements and maybe shorter ICU LOS w/ 4PCC than AA Decent size and like how they verified pts took a dose w/in 12 hrs of arrival bit.ly/4bG4ogp
Scott Dietrich tweet mediaScott Dietrich tweet media
English
0
10
39
4.8K
Paris Boeckman, PharmD, BCEMP retweetledi
Andy Webb
Andy Webb@AJWPharm·
Post-hoc analysis of the ULTRA trial shows that early TXA in good grade aSAH patients leads to WORSE functional outcomes than usual care. Outcomes in poor grade with similar. TXA is mostly harmless... but not fully harmless. Use it with care! neurology.org/doi/10.1212/WN…
Andy Webb tweet media
English
0
14
60
9.8K
Paris Boeckman, PharmD, BCEMP retweetledi
Eddy J. Gutierrez, MD
Eddy J. Gutierrez, MD@eddyjoemd·
Ketamine drips for sedation can be extremely effective. We just need to sort out/standardize the dosing regimen. This paper evaluates numerous published protocols in an attempt to make sense of it all. 🎩 tip to the authors. eddyjoemd.com/foamed/
Eddy J. Gutierrez, MD tweet media
English
2
57
214
18.2K
The propofol guru
The propofol guru@EMResusPharmD·
I haven’t posted on my “not a UTI” series in a while. Chest pain on inspiration. Denies any other S/Sx. Discharged on six days of Levaquin. Not pregnant, not undergoing urologic procedure. Ma’am, that’s a pube sample not a urine sample. Stop treating ASB #EMRx #TwitteRx
The propofol guru tweet media
English
1
0
19
2.2K
Paris Boeckman, PharmD, BCEMP retweetledi
Jerika Nguyễn-Klatt 
Jerika Nguyễn-Klatt @CritCareJer·
A brief summary of the literature on 2-bag fluid methods for DKA. What are you using? #PharmICU
Jerika Nguyễn-Klatt  tweet media
SCCM Clinical Pharmacy and Pharmacology Section@SCCM_CPP

#CPPPLU Highlights: In a retrospective study @AnnalsofPharm, a 2-bag DKA fluid order set reduced ⏰ to AG closure and β-hydroxybutyrate normalization. @mattroginski #PharmICU The fluid order set used in this study is summarized below by @CritCareJer. loom.ly/FZdvJSA

English
1
6
36
4.4K
Paris Boeckman, PharmD, BCEMP retweetledi
NEJM
NEJM@NEJM·
TIMELESS trial: Tenecteplase for thrombolysis in a 4.5-to-24-hour window did not improve disability outcomes at 90 days in patients with ischemic stroke who had been chosen on the basis of imaging. Most patients had endovascular thrombectomy. nej.md/3wa2tAR #ISC24
NEJM tweet media
English
1
59
142
36.8K
Paris Boeckman, PharmD, BCEMP retweetledi
AHA Science
AHA Science@AHAScience·
GWTG Stroke study found earlier reversal treatment for brain hemorrhage patients on blood thinners led to better outcomes especially in first 60 minutes or “golden hour." #GWTGResearch #ISC24 spr.ly/6010Vb7KM
English
1
10
24
7.1K